AcouSort receives 1.25 million SEK in Vinnova funding for the development of individualized stem cell treatments
AcouSort AB (publ) (”AcouSort”) receives funding from Vinnova for the project IndiCell. The aim of the project is to enable the transfer of novel stem cell treatments from research to a clinical setting. The project is planned to run over five years and generate revenues of 1.25 million SEK to AcouSort.– We are very excited to start this project where we will contribute with our unique acoustic technology to implement clinical work flows for individualized stem cell therapy. Together with the Blue4Therapy project, we now have two publicly funded projects relating to stem cell therapies.